Sales Highlights: Global • September 2024 Quarter AUD$1.5 million up 13% on prior quarter September 2024 Quarter AUD$1.0 million up 3% on prior quarter | --- | --- | |---------------|-------| | | | | Australia | | | North America | • | September 2024 Quarter AUD$0.5 million up 48% on prior quarter MELBOURNE, Australia, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian based and globally integrated biopharmaceutical company is pleased to announce continued strong sales ...